ArticleFrontiers in oncology2026
Gastric cancer and pleomorphic liposarcoma: A Case Report of synchronous dual primary malignancies.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 62-year-old male presented with a 9-month history of intermittent epigastric distension and pain, accompanied by acid reflux, nausea, vomiting, melena, and weight loss. Physical examination revealed epigastric tenderness. Laboratory tests showed hemoglobin of 94.0 g/L and serum albumin of 22.55 g/L. Gastroscopy identified gastric cancer in the antrum with gastric retention. Pathological biopsy of the antrum confirmed poorly differentiated adenocarcinoma. Colonoscopy revealed multiple small colonic polyps (maximum diameter 5 mm). Contrast-enhanced computed tomography (CT) of the upper abdomen demonstrated an approximately 6 cm lesion in the gastric antrum and a mesenchymal malignant tumor measuring approximately 10 cm in diameter in the left hepatorenal space, along with ascites in the abdominal and pelvic cavities. The patient received preoperative nutritional support, which improved his anemia, hypoalbuminemia, and overall physical condition. Under general anesthesia, he underwent distal gastrectomy with D2 lymph node dissection and Billroth II reconstruction, combined with resection of the retroperitoneal tumor. Postoperative pathology confirmed the gastric lesion as an ulcerative poorly differentiated adenocarcinoma and the retroperitoneal tumor as a pleomorphic liposarcoma (PLPS). The patient recovered well and was discharged. For the gastric cancer, he received 6 cycles of adjuvant chemotherapy with the SOX regimen (Oxaliplatin plus S-1). Follow-up examinations, including gastroscopy and contrast-enhanced CT of the upper abdomen, were performed at 3, 6, 12, 18, 24, 30, 36, 42, and 48 months postoperatively. No evidence of tumor recurrence was detected during this follow-up period. This paper reports a concurrent case of gastric cancer and PLPS, detailing the case characteristics, diagnostic and therapeutic procedures, and postoperative follow-up. The purpose of this study is to analyze the features of this Multiple primary malignant neoplasms (MPMN) case and provide a reference for selecting appropriate clinical treatments to improve patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.